<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><?properties no_embargo?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cereb Cortex</journal-id><journal-id journal-id-type="hwp">cercor</journal-id><journal-id journal-id-type="publisher-id">cercor</journal-id><journal-title>Cerebral Cortex (New York, NY)</journal-title><issn pub-type="ppub">1047-3211</issn><issn pub-type="epub">1460-2199</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1093/cercor/bhn204</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT<sub>2A</sub> Receptors</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>V&#x000e1;zquez-Borsetti</surname><given-names>Pablo</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cort&#x000e9;s</surname><given-names>Roser</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Artigas</surname><given-names>Francesc</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Neurochemistry and Neuropharmacology, Institut d'Investigacions Biom&#x000e8;diques de Barcelona (CSIC), IDIBAPS</aff><aff id="aff2"><label>2</label>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED)</aff><aff id="aff3"><label>3</label>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Salud Mental (CIBERSAM), 08036 Barcelona, Spain</aff><author-notes><corresp>Address correspondence to Francesc Artigas, PhD, Department of Neurochemistry, Institut d'Investigacions Biom&#x000e8;diques de Barcelona (CSIC), IDIBAPS, Rossell&#x000f3;, 161, 6th floor, 08036 Barcelona, Spain. Email: <email>fapnqi@iibb.csic.es</email>.</corresp></author-notes><!--Fake ppub date generated by PMC from publisher pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>7</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>21</day><month>11</month><year>2008</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>11</month><year>2008</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>19</volume><issue>7</issue><fpage>1678</fpage><lpage>1686</lpage><permissions><copyright-statement>&#x000a9; 2008 The Authors</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access"><p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/">http://creativecommons.org/licenses/by-nc/2.0/uk/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>The prefrontal cortex (PFC) is involved in higher brain functions altered in schizophrenia. Classical antipsychotics modulate cortico-limbic circuits mainly through subcortical D2 receptor blockade, whereas second generation (atypical) antipsychotics preferentially target cortical 5-HT receptors. Anatomical and functional evidence supports a PFC-based control of the brainstem monoaminergic nuclei. Using a combination of retrograde tracing experiments and in situ hybridization we report that a substantial proportion of PFC pyramidal neurons projecting to the dorsal raphe (DR) and/or ventral tegmental area (VTA) express 5-HT<sub>2A</sub> receptors. Cholera-toxin B application into the DR and the VTA retrogradely labeled projection neurons in the medial PFC (mPFC) and in orbitofrontal cortex (OFC). In situ hybridization of 5-HT<sub>2A</sub> receptor mRNA in the same tissue sections labeled a large neuronal population in mPFC and OFC. The percentage of DR-projecting neurons expressing 5-HT<sub>2A</sub> receptor mRNA was &#x0223c;60% in mPFC and &#x0223c;75% in OFC (<italic>n</italic> = 3). Equivalent values for VTA-projecting neurons were &#x0223c;55% in both mPFC and ventral OFC. Thus, 5-HT<sub>2A</sub> receptor activation/blockade in PFC may have downstream effects on dopaminergic and serotonergic systems via direct descending pathways. Atypical antipsychotics may distally modulate monoaminergic cells through PFC 5-HT<sub>2A</sub> receptor blockade, presumably decreasing the activity of neurons receiving direct cortical inputs<bold>.</bold></p></abstract><kwd-group><kwd>antipsychotics</kwd><kwd>dopamine</kwd><kwd>pyramidal neurons</kwd><kwd>schizophrenia</kwd><kwd>serotonin receptors</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The prefrontal cortex (PFC) is critically involved in many higher brain functions, including cognitive functions and behavioral control, which are altered in schizophrenic patients (<xref ref-type="bibr" rid="bib38">Lewis and Lieberman 2000</xref>; <xref ref-type="bibr" rid="bib20">Elvevag and Goldberg 2000</xref>; <xref ref-type="bibr" rid="bib74">Weinberger et al. 2001</xref>). Autopsy and neuroimaging studies have revealed the existence of a reduced PFC volume, reduced layer thickness, tight packing of pyramidal neurons and reduced neuropil in the brains of schizophrenic patients (<xref ref-type="bibr" rid="bib27">Harrison 1999</xref>; <xref ref-type="bibr" rid="bib61">Selemon and Goldman-Rakic 1999</xref>; <xref ref-type="bibr" rid="bib38">Lewis and Lieberman 2000</xref>). Alterations in key neurotransmitters such as glutamate, GABA, and dopamine (DA) have also been reported in PFC (<xref ref-type="bibr" rid="bib38">Lewis and Lieberman 2000</xref>; <xref ref-type="bibr" rid="bib9">Benes and Berretta 2001</xref>; <xref ref-type="bibr" rid="bib37">Lewis et al. 2005</xref>). Moreover, untreated schizophrenic patients show a reduced energy metabolism in the PFC which has been related with negative symptoms (<xref ref-type="bibr" rid="bib5">Andreasen et al. 1997</xref>; <xref ref-type="bibr" rid="bib54">Potkin et al. 2002</xref>) yet psychotic symptoms appear associated with hyperactivity of various cortical areas, including the PFC (<xref ref-type="bibr" rid="bib14">Catafau et al. 1994</xref>; <xref ref-type="bibr" rid="bib19">Dierks et al. 1999</xref>; <xref ref-type="bibr" rid="bib63">Shergill et al. 2000</xref>).</p><p>Classical antipsychotic drugs are thought to alleviate schizophrenia symptoms by dampening the overactivity of DA at D2 receptor in ventral striatum. In contrast, second generation (atypical) antipsychotics preferentially target serotonin (5-HT) receptors such as 5-HT<sub>2A</sub>, 5-HT<sub>2C</sub>, and 5-HT<sub>1A</sub> receptors (<xref ref-type="bibr" rid="bib11">Bymaster et al. 1996</xref>; <xref ref-type="bibr" rid="bib7">Arnt and Skarsfeldt 1998</xref>; <xref ref-type="bibr" rid="bib18">Chou et al. 2003</xref>). These receptors are densely expressed in various subfields of the rat PFC, particularly in its medial aspect (<xref ref-type="bibr" rid="bib51">Pompeiano et al. 1992</xref>, <xref ref-type="bibr" rid="bib52">1994</xref>). Recent studies have established their presence in a large proportion of PFC pyramidal and GABAergic neurons. In particular, 50&#x02013;60% of the pyramidal neurons in layers II/III and V of the medial PFC (mPFC) express 5-HT<sub>2A</sub> and/or 5-HT<sub>1A</sub> receptors (<xref ref-type="bibr" rid="bib4">Amarg&#x000f3;s-Bosch et al. 2004</xref>; <xref ref-type="bibr" rid="bib59">Santana et al. 2004</xref>).</p><p>Anatomical and electrophysiological studies have established the presence of direct afferents from cingulated (Cg), prelimbic (PL), and infralimbic (IL) areas of the PFC to the brainstem monoaminergic nuclei, including the dorsal raphe nucleus (DR) (<xref ref-type="bibr" rid="bib3">Aghajanian and Wang 1977</xref>; <xref ref-type="bibr" rid="bib26">Haj&#x000f3;s et al. 1998</xref>; <xref ref-type="bibr" rid="bib62">Sesack et al. 1989</xref>; <xref ref-type="bibr" rid="bib50">Peyron et al. 1998</xref>; <xref ref-type="bibr" rid="bib15">Celada et al. 2001</xref>) and the ventral tegmental area (VTA) (<xref ref-type="bibr" rid="bib67">Thierry et al. 1979</xref>, <xref ref-type="bibr" rid="bib66">1983</xref>; <xref ref-type="bibr" rid="bib69">Tong et al. 1996</xref>, <xref ref-type="bibr" rid="bib70">1998</xref>; <xref ref-type="bibr" rid="bib13">Carr and Sesack 2000</xref>). These nuclei give rise to the ascending serotonergic and dopaminergic innervation of most cortical and limbic brain regions, involved in numerous physiological functions and in severe psychiatric conditions such as major depression and schizophrenia (<xref ref-type="bibr" rid="bib12">Carlsson 1988</xref>; <xref ref-type="bibr" rid="bib30">Jacobs and Azmitia 1992</xref>; <xref ref-type="bibr" rid="bib73">Weinberger et al. 1994</xref>; <xref ref-type="bibr" rid="bib75">Williams and Goldman-Rakic 1995</xref>; <xref ref-type="bibr" rid="bib36">Laruelle et al. 1996</xref>; <xref ref-type="bibr" rid="bib58">Robbins 2000</xref>; <xref ref-type="bibr" rid="bib71">Tzschentke and Schmidt 2000</xref>; <xref ref-type="bibr" rid="bib60">Schultz 2004</xref>).</p><p>Previous studies have reported that the systemic administration of 5-HT<sub>2A</sub> receptor ligands such as DOI (5-HT<sub>2A/2C</sub> receptor agonist) or M100907 (selective 5-HT<sub>2A</sub> receptor antagonist) modulates the DA system (<xref ref-type="bibr" rid="bib24">Gobert and Millan 1999</xref>; <xref ref-type="bibr" rid="bib29">Ichikawa et al. 2001</xref>; <xref ref-type="bibr" rid="bib41">Minabe et al. 2001</xref>; <xref ref-type="bibr" rid="bib48">Pehek et al. 2001</xref>; <xref ref-type="bibr" rid="bib53">Porras et al. 2002</xref>), yet the location of the receptors responsible for these effects was unknown. More recently, it was reported that the local application of DOI in mPFC increased burst firing of DA cells in the VTA and the DA output in the mesocortical DA pathway (<xref ref-type="bibr" rid="bib10">Bortolozzi et al. 2005</xref>). Similarly, local DOI application in the mPFC enhanced the firing rate of DR 5-HT neurons and 5-HT output in rat mPFC (<xref ref-type="bibr" rid="bib39">Mart&#x000ed;n-Ruiz et al. 2001</xref>; <xref ref-type="bibr" rid="bib4">Amarg&#x000f3;s-Bosch et al., 2004</xref>). These observations suggested that the activity of the ascending cortical DA and 5-HT systems can be modulated by 5-HT<sub>2A</sub> receptor activation in pyramidal neurons projecting to midbrain.</p><p>In the present study, we provide histological support to this hypothesis by using a combination of tract-tracing techniques and subsequent in situ hybridization of 5-HT<sub>2A</sub> receptor mRNA in PFC sections containing retrogradely labeled neurons projecting to DR or VTA.</p></sec><sec sec-type="methods"><title>Experimental Procedures</title><sec><title>Animals</title><p>Male albino Wistar rats (Iffa Credo, Lyon, France) weighing 250&#x02013;300 g were used in this study. Animals were kept in a controlled environment (12-h light/dark cycle and 22 &#x000b1; 2 &#x000b0;C room temperature) with food and water provided ad libitum. All experimental procedures used in this study were in strict compliance with the Spanish legislation and the European Communities Council Directive on &#x0201c;Protection of Animals Used in Experimental and Other Scientific Purposes&#x0201d; of November 24, 1986 (86/609/EEC). Animal work was carried out in the animal facilities of the School of Medicine of the University of Barcelona and all protocols used were approved by its Ethical Committee for Animal Research and by the &#x0201c;Departament de Medi Ambient i Habitatge&#x0201d; from the Catalan Government (Generalitat de Catalunya).</p><p>Animals were deeply anesthetized with sodium pentobarbital (60 mg/kg ip), and placed in a stereotaxic frame (David Kopf Instruments). Glass capillary tubes were heated and pulled with a Narishige PE-2 pipette puller (Narishige Sci. Inst., Tokyo, Japan), Tips were broken to 30 &#x003bc;m diameter under microscopic control. The micropipettes were then filled with a solution of cholera-toxin B subunit (CTB, 2% in distilled water, List Biological Laboratories, Campbell, CA). CTB was iontophoretically injected into the DR (AP &#x02212;7.6 to &#x02212;7.8; L &#x02212;3.1 with a vertical 30&#x000b0; angle; DV &#x02212;6.2 to &#x02212;6.8; <italic>n</italic> = 3) or the VTA (AP &#x02212;5.6 to &#x02212;6.0; L &#x02212;0.5; DV &#x02212;8.2; <italic>n</italic> = 3). Stereotaxic coordinates were taken from the atlas of <xref ref-type="bibr" rid="bib46">Paxinos and Watson (1986)</xref>. The iontophoretic injections were performed using a 5 &#x003bc;A positive-pulsed direct current for a total of 5 min (7 s on/off for 10 min). After surgery, rats were housed individually. Ten days after surgery, the animals were anesthetized with an ip overdose of sodium pentobarbital and perfused transcardially with 50 mL of calcium-free Tyrode's solution (6.8 g/L NaCl; 0.4 g/L KCl; 0.32 g/L MgCl<sub>2</sub>&#x000b7;6H<sub>2</sub>O; 0.10 g/L MgSO<sub>4</sub>&#x000b7;7H<sub>2</sub>O; 0.17 g/L NaH<sub>2</sub>PO<sub>4</sub>&#x000b7;H<sub>2</sub>O; 2.2 g/L NaHCO<sub>3</sub>; 1.1 g/L glucose) containing 0.1% heparin at 37&#x000b0;C, followed by 50 mL of warm (37 &#x000b0;C) and 300 mL of cold (4 &#x000b0;C) fixative (4% paraformaldehyde in 0.1 M phosphate buffer, pH 6.9). After perfusion, the skull was opened and the brain carefully removed and stored for 2 days in a cryoprotective solution (10% sucrose in 0.1 M phosphate buffer, pH 7.4). The brains were then frozen by slow immersion into dry-ice chilled isopentane. Tissue sections, 14 &#x003bc;m thick, were cut on a microtome-cryostat (Microm HM500 OM, Walldorf, Germany), and thaw-mounted onto glass slides pretreated with Histogrip (Zymed Laboratories Inc., San Francisco, CA).</p></sec><sec><title>Localization of Injection Sites</title><p>Tissue sections taken at the level of the injection sites (VTA or DR) were incubated during 3&#x02013;4 days in a humid chamber at 4 &#x000b0;C with a rabbit antiserum anti-CTB (1:1000; Sigma, St Louis, MI) alone or in combination with sheep anti-tryptophan hydroxylase (TPH) antiserum (1:100; Chemicon Intl.) or an anti-tyrosine hydroxylase (TH) monoclonal antibody (1:1000; Diasorin, Stillwater, MN). Then the sections were rinsed in 0.1 M phosphate-buffered saline (PBS) and incubated for 30 min at 37 &#x000b0;C with appropriate combinations of the following antisera (1:500, Molecular Probes, Leiden, NL): AlexaFluor 546-conjugated goat anti-rabbit (for CTB) and AlexaFluor 488-conjugated goat anti-mouse (for TH) or AlexaFluor 488-conjugated donkey anti-rabbit (for CTB) and AlexaFluor 546-conjugated donkey anti-goat (for TPH). Finally, the sections were washed in PBS and coverslipped using Mowiol (Merck, Darmstadt, Germany). The sections were observed and photographed in an epifluorescence microscope (Nikon Eclipse E1000, Nikon, Tokyo, Japan).</p></sec><sec><title>In Situ Hybridization Histochemistry Procedure</title><p>Sections through the PFC from rats injected with CTB were hybridized with probes against the 5-HT<sub>2A</sub> receptor mRNA. We used simultaneously 3 oligonucleotide probes complementary to bases 128&#x02013;170, 1380&#x02013;1427, and 939&#x02013;987 (GenBank accession no. NM_017254) (<xref ref-type="bibr" rid="bib55">Pritchett et al., 1988</xref>). These probes were synthesized on a 380 Applied Biosystem DNA synthesizer (Foster City Biosystem, Foster City, CA) and purified on a 20% polyacrylamide/8 M urea preparative sequencing gel. The oligonucleotides (2 pmol each) were labeled at their 3&#x02032;-end with [<sup>33</sup>P]&#x003b1;-dATP (&#x0003e;2500 Ci/mmol; Perkin-Elmer, Boston, MA) using terminal deoxynucleotidyltransferase (Roche Diagnostics GmbH, Mannheim, Germany), and then purified by centrifugation using QIAquick Nucleotide Removal Kit (Qiagen GmbH, Hilden, Germany).</p><p>The protocols for in situ hybridization were based on previously described procedures (<xref ref-type="bibr" rid="bib68">Tomiyama et al. 1997</xref>). Briefly, frozen tissue sections were first brought to room temperature, fixed for 20 min at 4 &#x000b0;C in 4% paraformaldehyde in Dulbecco's PBS (1&#x000d7; dPBS: 8 mM Na<sub>2</sub>HPO<sub>4</sub>, 1.4 mM KH<sub>2</sub>PO<sub>4</sub>, 136 mM NaCl, 2.6 mM KCl), washed for 5 min in 3x PBS at room temperature, twice for 5 min each in 1&#x000d7; dPBS and incubated for 2 min at 21 &#x000b0;C in a solution of predigested pronase (Calbiochem, San Diego, CA) at a final concentration of 24 U/mL in 50 mM Tris&#x02013;HCl pH 7.5, 5 mM ethylenediaminetetraacetic acid. The enzymatic activity was stopped by immersion for 30 s in 2 mg/mL glycine in 1&#x000d7; dPBS. Tissues were finally rinsed in 1&#x000d7; dPBS and dehydrated through a graded series of ethanol. For hybridization, the labeled probes were diluted in a solution containing 50% formamide, 4&#x000d7; SSC (1&#x000d7; SSC: 150 mM NaCl, 15 mM sodium citrate), 1&#x000d7; Denhardt's solution (0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin), 10% dextran sulfate, 1% sarkosyl, 20 mM phosphate buffer pH 7.0, 250 &#x003bc;g/mL yeast tRNA and 500 &#x003bc;g/mL salmon sperm DNA. Tissue sections were covered with hybridization solution containing the labeled probe, overlaid with Nescofilm coverslips (Bando Chemical Ind., Kobe, Japan) and incubated overnight at 42 &#x000b0;C in humid boxes. Sections were then washed 4 times (45 min each) in washing buffer (0.6 M NaCl, 10 mM Tris&#x02013;HCl pH 7.5) at 60 &#x000b0;C and once in the same buffer at room temperature for 30 min.</p><p>The specificity of the hybridization signal obtained with the probes used has been previously established (<xref ref-type="bibr" rid="bib52">Pompeiano et al. 1994</xref>). These controls included the following procedures: 1) the thermal stability of the hybrids obtained was checked for every probe, 2) for a given oligonucleotide probe, the hybridization signal was completely blocked by competition of the labeled probe in the presence of 50-fold excess of the same unlabeled oligonucleotide, and 3) the distribution of the hybridization signal at the regional and cellular levels obtained with the 3 probes used independently was identical.</p></sec><sec><title>CTB Immunohistochemistry on Hybridized Sections</title><p>After the in situ hybridization protocol, tissue sections were kept for 15 min in Tris&#x02013;HCl buffer (0.10 M pH 7.5) containing 1 M NaCl, 2 mM MgCl<sup>2</sup>&#x000b7;6H2O, and 2% BSA. This buffer was also used in subsequent incubations and washes unless specified. The sections were first incubated for 4 h at 37 &#x000b0;C with rabbit anti-CTB antiserum (1:1000; Sigma, St. Louis, MI). Subsequently the sections were washed 3 times (5 min each) and then incubated 30 min with biotinylated goat anti-rabbit immunoglobulins (1:100, Vector Laboratories). After three 5-min washes, the sections were incubated for one hour in Vectastain Elite ABC solution (Vector Laboratories) in a low salt buffer (0.6 M NaCl, 10 mM Tris&#x02013;HCl pH 7.5). Sections were then washed 3 times and immersed in a solution of 0.5 mg/mL 3,3&#x02032;-diaminobenzidine (DAB, Sigma-Aldrich) in Tris&#x02013;HCl 0.05 M pH 7.5 containing 1 &#x003bc;L/mL H<sub>2</sub>O<sub>2</sub> until color development (in all cases less than 10 min). The reaction was stopped by 2 rinses in buffer. CTB staining appeared as brown/orange precipitate in the soma and proximal dendrites of retrogradely labeled neurons. The sections were then briefly dipped in 70 and 100% ethanol, air-dried and dipped into Ilford K5 nuclear emulsion (Ilford, Mobberly, Cheshire, UK) diluted 1:1 with distilled water. They were exposed in the dark at 4 &#x000b0;C for 6 weeks and were finally developed in Kodak D19 (Kodak, Rochester, NY) for 5 min, fixed in Ilford Hypam fixer (Ilford), washed, and coverslipped using Mowiol (Merck).</p></sec><sec><title>Analysis of the Results</title><p>Tissue sections processed for in situ hybridization followed by immunohistochemical detection of CTB were examined in a Nikon Eclipse E1000 microscope (Nikon, Tokyo, Japan). Cell counting was performed manually at the microscope with the help of &#x0201c;analySIS&#x0201d; software (Soft Imaging System GmbH, Germany) in 1&#x02013;3 coronal sections of each rat corresponding to approximately +3.2 mm from Bregma, according to atlases of the rat brain (<xref ref-type="bibr" rid="bib46">Paxinos and Watson 1986</xref>; <xref ref-type="bibr" rid="bib64">Swanson 1999</xref>) DAB-labeled cells were considered positive when a dark precipitate was clearly distinguished from background. Only CTB-labeled cells showing great abundance of 5-HT<sub>2A</sub> receptor mRNA signal (densities of silver grains &#x0003e;3-fold greater than average background) were considered positive for both markers. Using this procedure, we cannot discard that the number of 5-HT<sub>2A</sub> receptor-bearing neurons has been somehow underestimated. We preferred this to a false-positive identification of 5-HT<sub>2A</sub> receptor-expressing neurons. Because the presence of high densities of autoradiographic silver grains might sometimes mask DAB-labeling, cells in the preparations were systematically examined at different focal planes to see CTB-immunoreactivity at lower planes and hybridization signal at upper planes. Micrography was performed using a digital camera (Color View 12) and the software &#x0201c;analySIS&#x0201d; on a Nikon Eclipse E1000 microscope (Nikon) or an Olympus NewCast microscope (Olympus, NL). Digital images were treated with Adobe Photoshop (Adobe Software, Mountain View, CA) to adjust only brightness, contrast and size to make the final figures.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The data reported here correspond to 6 rats in which CTB was microiontophoretically applied into the VTA or the DR (<italic>n</italic> = 3 for each site). In all cases, the applied CTB was confined within the respective nucleus, as shown by the colocalization of the tracer and the markers for dopaminergic neurons of the VTA (TH) and serotonergic neurons of the DR (TPH). <xref ref-type="fig" rid="fig1">Figure 1</xref> shows representative fluorescence microscope images illustrating the localization of CTB in the VTA (1A&#x02013;C) and the DR (1D&#x02013;F) of 2 of the rats used in the study. Schematic drawings in <xref ref-type="fig" rid="fig2">Figure 2</xref> illustrate the location of the different microinjections performed in the VTA and DR.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><p>Double immunolabeling showing the localization of CTB injection sites in the VTA (<italic>A</italic>) TH (red), (<italic>B</italic>) CTB (green), and (<italic>C</italic>) overlay and in the DR (<italic>D</italic>) TPH (green), (<italic>E</italic>) CTB (red), and (<italic>F</italic>) overlay. The images were taken at the fluorescence microscope from rats V1 and D1, respectively, and were merged using the software &#x0201c;analySIS.&#x0201d; Scale bar: 100 &#x003bc;m.</p></caption><graphic xlink:href="cercorbhn204f01_4c"/></fig><fig id="fig2" position="float"><label>Figure 2.</label><caption><p>Schematic drawings of coronal sections through the VTA (<italic>A</italic>) and the DR (<italic>B</italic>) illustrate the precise location of CTB injections (shaded areas) in the different rats used in this study as assessed by CTB immunostaining. Drawings were taken from <xref ref-type="bibr" rid="bib64">Swanson (1999)</xref>.</p></caption><graphic xlink:href="cercorbhn204f02_ht"/></fig><p>The application of CTB in the DR or the VTA resulted in the labeling of pyramidal neurons in layer V and superficial aspect of layer VI in the mPFC, including the Cg, PL, and IL subdivisions. CTB-labeled neurons were also found in the orbitofrontal cortex (OFC). These cells were located mainly in the ventral OFC of VTA-injected rats whereas they extended more laterally, reaching the agranular insular cortex in rats injected with CTB in the DR. Tracer application in the DR resulted in the labeling of PFC neurons in both hemispheres, whereas the application in the VTA labeled almost exclusively neurons in the ipsilateral hemisphere. <xref ref-type="fig" rid="fig3">Figure 3</xref> shows the schematic location of CTB-retrogradely labeled neurons in the PFC of 2 rats (V2 and D2 in <xref ref-type="table" rid="tbl1">Tables 1</xref> and <xref ref-type="table" rid="tbl2">2</xref>, respectively) injected with the tracer in the VTA (V2, <xref ref-type="fig" rid="fig3">Fig. 3<italic>A</italic></xref>) and in the DR (D2, <xref ref-type="fig" rid="fig3">Fig. 3<italic>B</italic></xref>), respectively. Each dot corresponds to 3 CTB-labeled pyramidal neurons.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>5-HT<sub>2A</sub> receptor expression in PFC neurons projecting to VTA</p></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">Rat</td><td rowspan="1" colspan="1">PFC region</td><td rowspan="1" colspan="1">CTB+</td><td rowspan="1" colspan="1">CTB+/5HT<sub>2A</sub>+</td><td rowspan="1" colspan="1">% Double-labeled cells</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">V1</td><td rowspan="1" colspan="1">mPFC</td><td align="char" char="." rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">43</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OFC (ventral)</td><td align="char" char="." rowspan="1" colspan="1">21</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">45</td></tr><tr><td rowspan="1" colspan="1">V2</td><td rowspan="1" colspan="1">mPFC</td><td align="char" char="." rowspan="1" colspan="1">17</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">59</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OFC (ventral)</td><td align="char" char="." rowspan="1" colspan="1">14</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">65</td></tr><tr><td rowspan="1" colspan="1">V3</td><td rowspan="1" colspan="1">mPFC</td><td align="char" char="." rowspan="1" colspan="1">90</td><td align="char" char="." rowspan="1" colspan="1">54</td><td align="char" char="." rowspan="1" colspan="1">60</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OFC (ventral)</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr></tbody></table><table-wrap-foot><fn><p>Note: Values are numbers of CTB-positive neurons in each structure (1&#x02013;2 sections per rat), as determined by CTB-immunoreactivity (CTB+). CTB-positive neurons that are also positive for the 5-HT<sub>2A</sub> receptor transcript (CTB+/5-HT<sub>2A</sub>+), were identified by the presence of the 2 markers (see Methods). Only neurons with unambiguous labeling for both markers were considered positive, as in the examples shown in <xref ref-type="fig" rid="fig3">Figure 3<italic>B</italic></xref>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>5-HT<sub>2A</sub> receptor expression in PFC neurons projecting to DR</p></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">Rat</td><td rowspan="1" colspan="1">PFC region</td><td rowspan="1" colspan="1">CTB+</td><td rowspan="1" colspan="1">CTB+/5HT<sub>2A</sub>+</td><td rowspan="1" colspan="1">% Double-labeled cells</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">D1</td><td rowspan="1" colspan="1">mPFC, ipsilateral<xref ref-type="table-fn" rid="tblfn1">a</xref></td><td align="char" char="." rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">58</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OFC, ipsilateral<xref ref-type="table-fn" rid="tblfn1">a</xref></td><td align="char" char="." rowspan="1" colspan="1">19</td><td align="char" char="." rowspan="1" colspan="1">13</td><td align="char" char="." rowspan="1" colspan="1">68</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">mPFC contralateral<xref ref-type="table-fn" rid="tblfn1">a</xref></td><td align="char" char="." rowspan="1" colspan="1">19</td><td align="char" char="." rowspan="1" colspan="1">13</td><td align="char" char="." rowspan="1" colspan="1">68</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OFC contralateral<xref ref-type="table-fn" rid="tblfn1">a</xref></td><td align="char" char="." rowspan="1" colspan="1">21</td><td align="char" char="." rowspan="1" colspan="1">18</td><td align="char" char="." rowspan="1" colspan="1">86</td></tr><tr><td rowspan="1" colspan="1">D2</td><td rowspan="1" colspan="1">mPFC, ipsilateral</td><td align="char" char="." rowspan="1" colspan="1">30</td><td align="char" char="." rowspan="1" colspan="1">20</td><td align="char" char="." rowspan="1" colspan="1">67</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OFC, ipsilateral</td><td align="char" char="." rowspan="1" colspan="1">38</td><td align="char" char="." rowspan="1" colspan="1">30</td><td align="char" char="." rowspan="1" colspan="1">79</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">mPFC contralateral</td><td align="char" char="." rowspan="1" colspan="1">23</td><td align="char" char="." rowspan="1" colspan="1">14</td><td align="char" char="." rowspan="1" colspan="1">61</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OFC contralateral</td><td align="char" char="." rowspan="1" colspan="1">30</td><td align="char" char="." rowspan="1" colspan="1">23</td><td align="char" char="." rowspan="1" colspan="1">77</td></tr><tr><td rowspan="1" colspan="1">D3</td><td rowspan="1" colspan="1">mPFC, ipsilateral</td><td align="char" char="." rowspan="1" colspan="1">19</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">58</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OFC, ipsilateral</td><td align="char" char="." rowspan="1" colspan="1">42</td><td align="char" char="." rowspan="1" colspan="1">26</td><td align="char" char="." rowspan="1" colspan="1">61</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">mPFC contralateral</td><td align="char" char="." rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">67</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OFC contralateral</td><td align="char" char="." rowspan="1" colspan="1">27</td><td align="char" char="." rowspan="1" colspan="1">22</td><td align="char" char="." rowspan="1" colspan="1">81</td></tr></tbody></table><table-wrap-foot><fn><p>Note: Values are the numbers of CTB-positive neurons in each structure (2 sections per rat), as determined by CTB-immunoreactivity (CTB+). CTB-positive neurons that are also positive for the 5-HT<sub>2A</sub> receptor transcript (CTB+/5HT<sub>2A</sub>+), were identified by the presence of the 2 markers (see Methods). Only neurons with unambiguous labeling for both markers were considered positive, as in the examples shown in <xref ref-type="fig" rid="fig4">Figures 4<italic>B</italic></xref> and <xref ref-type="fig" rid="fig5">5<italic>B</italic></xref>.</p></fn><fn id="tblfn1"><label>a</label><p>CTB application was aimed at the midline in the DR. However, the micropipette entered the brain with an angle of 30&#x000b0; to avoid the sinus. Thus, we use the term ipsilateral to refer to the brain hemisphere where the micropipette first entered the midbrain.</p></fn></table-wrap-foot></table-wrap><fig id="fig3" position="float"><label>Figure 3.</label><caption><p>Schematic drawings of coronal sections through the PFC illustrating the localization of CTB-retrogradelly labeled cells after tracer injections in the VTA of rat V2 (<italic>A</italic>) and the DR of rat D2 (<italic>B</italic>). Every dot represents 3 labeled cell bodies. (<italic>A</italic>) CTB injections in the VTA only labeled cell bodies in the ipsilateral (i) mPFC (including Cg, PL, and IL) and medial (ventral) part of the OFC. (<italic>B</italic>) CTB injections in the DR labeled cell in the mPFC and OFC of both ipsilateral and contralateral (c) hemispheres. Drawings were taken from <xref ref-type="bibr" rid="bib46">Paxinos and Watson (1986)</xref>.</p></caption><graphic xlink:href="cercorbhn204f03_lw"/></fig><p><xref ref-type="fig" rid="fig4">Figure 4</xref> shows 5-HT<sub>2A</sub> receptor mRNA labeling in VTA-projecting neurons in the mPFC. The presence of the 5-HT<sub>2A</sub> receptor mRNA was established by dense clusters of silver grains, clearly distinguishable from background. As previously observed (<xref ref-type="bibr" rid="bib4">Amarg&#x000f3;s-Bosch et al. 2004</xref>; <xref ref-type="bibr" rid="bib59">Santana et al. 2004</xref>), a large proportion of cells in the Cg, PL, and IL subdivisions of the PFC were found that contained the 5-HT<sub>2A</sub> receptor transcript, mainly in layers II/III and V. No 5-HT<sub>2A</sub> receptor-positive cells were found in layer I and a lower abundance of 5-HT<sub>2A</sub> receptor-positive cells was observed in layer VI compared with layers III&#x02013;V. In occasions, the density of silver grains made difficult the detection of CTB-immunoreactivity. In these cases, and because CTB-immunoreactivity and silver grains are localized at different depths of the tissue preparation, a careful inspection of individual cells was performed by examining different planes of the preparation, which contain the CTB signal (lower plane) and the emulsion for in situ hybridization (upper plane). <xref ref-type="table" rid="tbl1">Table 1</xref> shows the number of CTB-positive cells and the percentage of double-labeled cells in the mPFC and ventral OFC of the 3 rats injected with CTB in the VTA. The percentage of CTB-positive cells that expressed 5-HT<sub>2A</sub> receptors in the mPFC was rather high and homogenous (43&#x02013;60%; 54 &#x000b1; 6% on average). Two of the rats also exhibited a moderate-high (45&#x02013;65%) percentage of CTB-positive neurons expressing the 5-HT<sub>2A</sub> receptor in the ventral OFC. No unambiguous CTB-positive cells could be detected in the third animal. It is likely that these individual differences depend on the size and precise site of injection of CTB within the VTA. Representative examples of single-labeled (CTB- or 5-HT<sub>2A</sub> receptor mRNA positive) and double-labeled (CTB- and 5-HT<sub>2A</sub> receptor mRNA positive) cells are shown at a high magnification in <xref ref-type="fig" rid="fig4">Figure 4<italic>C</italic>&#x02013;<italic>E</italic></xref>.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><p>Colocalization of 5-HT<sub>2A</sub> receptor mRNA hybridization signal and CTB-immunoreactivity in the mPFC after injection of the tracer in the VTA. (<italic>A</italic>) Clusters of autoradiographic grains corresponding to 5-HT<sub>2A</sub> receptor mRNA-containing cells are clearly visible in layers II&#x02013;VI at a low magnification; the strongest signal is found in layer V neurons. The boxed area is shown in (<italic>B</italic>) at a higher magnification. (<italic>B</italic>) CTB-immunoreactivity (brown precipitate) can be seen in some cells under the hybridization signal (red&#x02013;blue double arrowheads), whereas other cells display only 5-HT<sub>2A</sub> receptor mRNA signal (blue arrowheads). (<italic>C</italic>) Detail of a CTB-immunoreactive neuron which lacks the hybridization signal. (<italic>D</italic>) Detail of a double-labeled neuron containing CTB-immunoreactivity and a strong 5-HT<sub>2A</sub> receptor mRNA hybridization signal. (<italic>E</italic>) Detail of a cell profile showing 5-HT<sub>2A</sub> receptor mRNA signal without CTB-immunoreactivity. Bars: 200 &#x003bc;m (<italic>A</italic>), 30 &#x003bc;m (<italic>B</italic>), 10 &#x003bc;m (<italic>C</italic>&#x02013;<italic>E</italic>).</p></caption><graphic xlink:href="cercorbhn204f04_4c"/></fig><p>A large proportion of CTB-positive pyramidal neurons in the mPFC and OFC of both hemispheres as labeled by tracer application in the DR also contained 5-HT<sub>2A</sub> receptor transcripts (<xref ref-type="fig" rid="fig5">Figs 5</xref>, <xref ref-type="fig" rid="fig6">6</xref> and <xref ref-type="table" rid="tbl2">Table 2</xref>). The percentage of CTB-positive cells that expressed 5-HT<sub>2A</sub> receptors was also high and showed little variability in the 3 rats examined. Representative examples of single-labeled (CTB- or 5-HT<sub>2A</sub> receptor mRNA positive) and double-labeled (CTB- and 5-HT<sub>2A</sub> receptor mRNA positive) cells are shown at a high magnification in <xref ref-type="fig" rid="fig5">Figures 5C&#x02013;E</xref> and <xref ref-type="fig" rid="fig6">6C&#x02013;E</xref>.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><p>Colocalization of 5-HT<sub>2A</sub> receptor mRNA hybridization signal and CTB-immunoreactivity in the mPFC after injection of the tracer in the DR. (<italic>A</italic>) Clusters of autoradiographic grains corresponding to 5-HT<sub>2A</sub> receptor mRNA-containing cells are clearly visible in layers II&#x02013;VI at a low magnification. The boxed area is show in (<italic>B</italic>) at a higher magnification. (<italic>B</italic>) CTB-immunoreactivity (brown precipitate) can be seen in some cells under the hybridization signal (red&#x02013;blue double arrowheads) and in cells lacking hybridization signal (red arrowheads), whereas other cells display only 5-HT<sub>2A</sub> receptor mRNA signal (blue arrowheads). (<italic>C</italic>) Detail of a CTB-immunoreactive neuron which lacks the hybridization signal. (<italic>D</italic>) Detail of a double-labeled neuron containing CTB-immunoreactivity and a strong 5-HT<sub>2A</sub> receptor mRNA hybridization signal. (<italic>E</italic>) Detail of a cell profile showing 5-HT<sub>2A</sub> receptor mRNA signal without CTB-immunoreactivity. Bars: 200 &#x003bc;m (<italic>A</italic>), 30 &#x003bc;m (<italic>B</italic>), 10 &#x003bc;m (<italic>C</italic>&#x02013;<italic>E</italic>).</p></caption><graphic xlink:href="cercorbhn204f05_4c"/></fig><fig id="fig6" position="float"><label>Figure 6.</label><caption><p>Colocalization of 5-HT<sub>2A</sub> receptor mRNA hybridization signal and CTB-immunoreactivity in the OFC after injection of the tracer in the DR. (<italic>A</italic>) Clusters of autoradiographic grains corresponding to 5-HT<sub>2A</sub> receptor mRNA-containing cells are clearly visible at a low magnification. The boxed area is show in (<italic>B</italic>) at a higher magnification. (<italic>B</italic>) CTB-immunoreactivity (brown precipitate) can be seen in some cells under the hybridization signal (red-blue double arrowheads) and in cells lacking hybridization signal (red arrowheads), whereas other cells display only 5-HT<sub>2A</sub> receptor mRNA signal (blue arrowheads). (<italic>C</italic>) Detail of a CTB-immunoreactive neuron which lacks of hybridization signal. (<italic>D</italic>) Detail of a double-labeled neuron containing CTB-immunoreactivity and 5-HT<sub>2A</sub> receptor mRNA hybridization signal. (<italic>E</italic>) Detail of a cell profile showing 5-HT<sub>2A</sub> receptor mRNA signal without CTB-immunoreactivity. Bars: 200 &#x003bc;m (<italic>A</italic>), 30 &#x003bc;m (<italic>B</italic>), 10 &#x003bc;m (<italic>C</italic>&#x02013;<italic>E</italic>).</p></caption><graphic xlink:href="cercorbhn204f06_4c"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>The present results indicate that a substantial proportion (&#x0003e;50% on average) of pyramidal neurons in the PFC projecting to the midbrain monoaminergic nuclei (DR and/or VTA) contain the 5-HT<sub>2A</sub> receptor transcript. These results provide anatomical evidence for the existence of a PFC-based, 5-HT<sub>2A</sub> receptor-mediated distal control of the activity of the ascending dopaminergic and serotonergic systems. From a psychopharmacological perspective, the present data suggest that the interaction of atypical antipsychotics with 5-HT<sub>2A</sub> receptors in the PFC may decrease the excitatory PFC input onto selected neuronal populations within the DR and the VTA and consequently modulate the activity of the ascending dopaminergic and serotonergic systems.</p><sec><title>Methodological Considerations</title><p>5-HT<sub>2A</sub> receptors are expressed in high densities in PFC (<xref ref-type="bibr" rid="bib47">Pazos et al. 1985</xref>; <xref ref-type="bibr" rid="bib52">Pompeiano et al. 1994</xref>). More recent data using double in situ hybridization indicate that &#x0223c;50&#x02013;60% pyramidal neurons and &#x0223c;20&#x02013;30% GABAergic neurons in layers II&#x02013;V of the mPFC contain the 5-HT<sub>2A</sub> receptor mRNA (<xref ref-type="bibr" rid="bib59">Santana et al. 2004</xref>). Our results are consistent with these previous observations and show the presence of a high number of 5-HT<sub>2A</sub> receptor mRNA-expressing cells in the Cg, PL, and IL subdivisions of the PFC, mainly in layers II&#x02013;V and a lower abundance in layer VI, as observed previously (<xref ref-type="bibr" rid="bib52">Pompeiano et al. 1994</xref>; <xref ref-type="bibr" rid="bib4">Amarg&#x000f3;s-Bosch et al. 2004</xref>; <xref ref-type="bibr" rid="bib59">Santana et al. 2004</xref>). This demonstrates that the in situ hybridization procedure reliably labeled 5-HT<sub>2A</sub> receptor-expressing cells in the present experimental conditions, that is, when the hybridization procedure was followed by immunostaining of CTB in the same tissue sections. The present methodology has also been used to determine the presence of 5-HT<sub>4</sub> receptors in PFC neurons projecting to VTA (Pe&#x000f1;as et al., manuscript in preparation). Recent reports have used riboprobes in combination with tract tracers (<xref ref-type="bibr" rid="bib28">Hur and Zaborszky 2005</xref>; <xref ref-type="bibr" rid="bib49">Perez-Manso et al. 2006</xref>; <xref ref-type="bibr" rid="bib76">Yokota et al. 2007</xref>; <xref ref-type="bibr" rid="bib8">Barroso-Chinea et al. 2008</xref>). The present study indicates that, similarly to riboprobes, oligonucleotides can be reliably combined with tracer immunohistochemistry to identify proteins expressed in relatively low levels, such as monoamine receptors, in projection neurons.</p><p>CTB-immunoreactive cells were clearly detected in tissue sections previously treated for in situ hybridization. In the PFC, these cells were exclusively located in the medial and orbital divisions. This distribution agrees well with that reported previously using electrophysiological and tract-tracing methods for DR- and VTA-projecting neurons (<xref ref-type="bibr" rid="bib3">Aghajanian and Wang 1977</xref>; <xref ref-type="bibr" rid="bib67">Thierry et al. 1979</xref>; <xref ref-type="bibr" rid="bib66">Thierry et al. 1983</xref>; <xref ref-type="bibr" rid="bib62">Sesack et al. 1989</xref>; <xref ref-type="bibr" rid="bib50">Peyron et al. 1998</xref>; <xref ref-type="bibr" rid="bib31">Jankowski and Sesack 2004</xref>; <xref ref-type="bibr" rid="bib22">Gabbott et al. 2005</xref>; <xref ref-type="bibr" rid="bib23">Geisler and Zahm 2005</xref>). One possible limitation of the use of CTB is the uptake by damaged fibers of passage close to the application site. This might be a potential confounding factor, particularly for the identification of VTA-projecting neurons, given the proximity of the VTA to the medial forebrain bundle. CTB has been reported to be taken up by fibers of passage (<xref ref-type="bibr" rid="bib17">Chen and Aston-Jones 1995</xref>). However, this potential limitation can be minimized by the microiontophoretic application of the tracer, as used herein. This procedure resulted in a tracer distribution within the boundaries of the DR and VTA as observed by the coincidence of the tracer with the TPH and TH immunoreactivity used to label 5-HT and DA neurons, respectively. Nonspecific uptake by damaged fibers of the medial forebrain bundle during CTB application in the VTA would have resulted in labeling of pyramidal neurons in other PFC areas, particularly in the primary and secondary motor areas, that contain the largest proportion of corticospinal fibers of all PFC subdivisions (<xref ref-type="bibr" rid="bib22">Gabbott et al. 2005</xref>). Such labeling was not observed in any of the rats, which further supports the specificity of the labeling procedure. Only in one rat (D1), CTB labeled a neighboring area in addition to the DR itself, yet the percentage of double-labeled cells in the PFC was similar to the rest.</p><p>The number of CTB-immunoreactive neurons in the mPFC was lower when the CTB immunohistochemistry was conducted in sections previously subjected to in situ hybridization (data not shown). This difference may be attributed to the previous tissue exposure to the hybridizing conditions and/or the high salt concentration used in the immunohistochemical procedure. However, this limitation is unlikely to affect the conclusions of the present study, because we calculated the proportion of 5-HT<sub>2A</sub> receptor mRNA-positive neurons by reference to the total number of CTB-positive neurons visualized and not vice versa.</p></sec><sec><title>Functional Implications</title><p>A large body of data in the literature indicates that the activation of 5-HT<sub>2A</sub> receptors by 5-HT results in neuronal depolarization, reduction of the afterhyperpolarization and increase of excitatory postsynaptic currents and of the discharge rate in pyramidal neurons of the PFC (<xref ref-type="bibr" rid="bib6">Araneda and Andrade 1991</xref>; <xref ref-type="bibr" rid="bib65">Tanaka and North 1993</xref>; <xref ref-type="bibr" rid="bib1">Aghajanian and Marek 1997</xref>, <xref ref-type="bibr" rid="bib2">1999</xref>; <xref ref-type="bibr" rid="bib4">Amarg&#x000f3;s-Bosch et al. 2004</xref>; <xref ref-type="bibr" rid="bib56">Puig et al. 2005</xref>; <xref ref-type="bibr" rid="bib72">Villalobos et al. 2005</xref>). 5-HT can also activate 5-HT<sub>2A</sub> receptors in GABA interneurons to increase a synaptic GABA input onto pyramidal neurons (<xref ref-type="bibr" rid="bib65">Tanaka and North 1993</xref>; <xref ref-type="bibr" rid="bib77">Zhou and Hablitz 1999</xref>). Hallucinogens such as DOI DOB or LSD also modify membrane properties of pyramidal neurons and evoke marked cellular and network changes in PFC in vivo and in vitro through the activation of 5-HT<sub>2A</sub> receptors (<xref ref-type="bibr" rid="bib1">Aghajanian and Marek 1997</xref>, <xref ref-type="bibr" rid="bib2">1999</xref>; <xref ref-type="bibr" rid="bib57">Puig et al. 2003</xref>; <xref ref-type="bibr" rid="bib72">Villalobos et al. 2005</xref>; <xref ref-type="bibr" rid="bib25">Gonzalez-Maeso et al. 2007</xref>; <xref ref-type="bibr" rid="bib34">Lambe and Aghajanian 2007</xref>; <xref ref-type="bibr" rid="bib16">Celada et al. 2008</xref>).</p><p>The present histological data, together with these functional observations suggest that activation of 5-HT<sub>2A</sub> receptors in mPFC pyramidal neurons may increase excitatory inputs onto DA and 5-HT neurons in the VTA and DR, respectively, as well as on GABAergic neurons in both nuclei. This is consistent with the existence of monosynaptic pathways from the PFC to monoaminergic and GABAergic neurons of the VTA and the DR (<xref ref-type="bibr" rid="bib3">Aghajanian and Wang 1977</xref>; <xref ref-type="bibr" rid="bib67">Thierry et al. 1979</xref>, <xref ref-type="bibr" rid="bib66">1983</xref>; <xref ref-type="bibr" rid="bib62">Sesack et al. 1989</xref>; <xref ref-type="bibr" rid="bib69">Tong et al. 1996</xref>, <xref ref-type="bibr" rid="bib70">1998</xref>; <xref ref-type="bibr" rid="bib26">Haj&#x000f3;s et al. 1998</xref>; <xref ref-type="bibr" rid="bib50">Peyron et al. 1998</xref>; <xref ref-type="bibr" rid="bib15">Celada et al. 2001</xref>; <xref ref-type="bibr" rid="bib31">Jankowski and Sesack 2004</xref>; <xref ref-type="bibr" rid="bib22">Gabbott et al. 2005</xref>; <xref ref-type="bibr" rid="bib23">Geisler and Zahm 2005</xref>). It is also consistent with the presence of a high density of layer V pyramidal neurons expressing 5-HT<sub>2A</sub> receptors (<xref ref-type="bibr" rid="bib59">Santana et al. 2004</xref>) some of which project to DR and/or VTA, as shown herein. Hence, the systemic administration of 5-HT<sub>2A</sub> receptor agonists/antagonists can distally modulate the activity of the ascending serotonergic and dopaminergic pathways originated in the DR and VTA, respectively, via PFC 5-HT<sub>2A</sub> receptors. In support of this view is also the fact that local application of the preferential 5-HT<sub>2A</sub> receptor agonist DOI in rat mPFC increased the firing rate of a subpopulation of DR 5-HT neurons, increased burst firing of DA neurons in the VTA and elevated the release of both monoamines in PFC (<xref ref-type="bibr" rid="bib39">Mart&#x000ed;n-Ruiz et al. 2001</xref>; <xref ref-type="bibr" rid="bib10">Bortolozzi et al. 2005</xref>). Notwithstanding the existence of this direct pathway between the PFC and the VTA involving 5-HT<sub>2A</sub> receptors, indirect pathways controlling the activity of VTA neurons cannot be excluded. Thus, the electrical stimulation of the mPFC evokes monosynaptic excitatory responses as well as GABA<sub>A</sub>- and 5-HT<sub>1A</sub> receptor-mediated inhibitory responses in DR 5-HT neurons, indicating that most PFC-driven control of 5-HT neurons occurs via mono- and bisynaptic inputs (<xref ref-type="bibr" rid="bib26">Haj&#x000f3;s et al. 1998</xref>; <xref ref-type="bibr" rid="bib15">Celada et al. 2001</xref>; <xref ref-type="bibr" rid="bib31">Jankowski and Sesack 2004</xref>). However, this is not the case for DA neurons in the VTA which, in addition to short monosynaptic excitations consistent with direct inputs from mPFC (<xref ref-type="bibr" rid="bib67">Thierry et al. 1979</xref>), show complex biphasic responses to mPFC stimulation (<xref ref-type="bibr" rid="bib69">Tong et al. 1996</xref>). Such biphasic responses might involve alternative pathways such as: 1) PFC &#x02192; laterodorsal/pedunculopontine tegmental nuclei &#x02192; VTA, and 2) PFC &#x02192; nucleus accumbens &#x02192; ventral pallidum &#x02192; VTA. These pathways, may also be accountable for an indirect 5-HT<sub>2A</sub> receptor-mediated control of DA neurons, and both have been shown to modulate DA neuron activity via phasic and tonic inputs, respectively (<xref ref-type="bibr" rid="bib21">Floresco et al. 2003</xref>).</p><p>The present results may have functional implications in terms of the interaction between both neurotransmitter systems (e.g., indirect, PFC-mediated vs. direct DR-VTA, interactions mediated by 5-HT<sub>2A</sub> receptors in the VTA; <xref ref-type="bibr" rid="bib42">Nocjar et al. 2002</xref>). They may also be relevant for the mechanism of action of atypical antipsychotic drugs. Most agents of this therapeutic group show greater affinity for 5-HT<sub>2A</sub> receptors than for DA D2 receptors and produce a greater occupancy of cortical 5-HT<sub>2</sub> than of subcortical D2 receptors at therapeutic doses (<xref ref-type="bibr" rid="bib45">Nyberg et al. 1998</xref>; <xref ref-type="bibr" rid="bib40">Meltzer 1999</xref>). Clozapine, the prototypical representative of this group, does not reach&#x02014;even at very high doses&#x02014;the 70% of D2 receptor occupancy, considered to be the threshold of therapeutic efficacy for classical antipsychotics (<xref ref-type="bibr" rid="bib43">Nordstrom et al. 1998</xref>; <xref ref-type="bibr" rid="bib32">Kapur et al. 1999</xref>; <xref ref-type="bibr" rid="bib44">Nyberg et al. 1999</xref>). It is unclear how 5-HT<sub>2A</sub> receptor blockade may contribute to the therapeutic action of atypical antipsychotics. Taken together, the present and previous data suggest that the blockade of 5-HT<sub>2A</sub> receptors in PFC may attenuate excitatory inputs from PFC to selected neuronal groups in the VTA, thus modulating dopaminergic activity. According to the known connectivity between mPFC and DA and GABA neurons in the VTA (<xref ref-type="bibr" rid="bib13">Carr and Sesack 2000</xref>), this should primarily affect dopaminergic neurons projecting back to the mPFC and to limbic areas other than the nucleus accumbens as well as GABA neurons projecting to the latter nucleus. However, the recent demonstration of marked differences in the functional properties of mesocortical vs. mesolimbic DA VTA neurons (<xref ref-type="bibr" rid="bib35">Lammel et al. 2008</xref>) and the fact that VTA GABA neurons may indirectly affect DA neuronal activity make difficult to predict the extent of the 5-HT<sub>2A</sub> receptor-mediated excitatory inputs on mesolimbic DA neurons in the VTA. Indeed, previous evidence from this laboratory indicated a widespread effect of the local (in mPFC) and systemic application of DOI in a proportion of VTA DA neurons that exceeded by and large the low abundance of mesocortical neurons (<xref ref-type="bibr" rid="bib10">Bortolozzi et al. 2005</xref>). Also, the fact that DOI potentiates the amphetamine-induced release of DA in the nucleus accumbens (<xref ref-type="bibr" rid="bib33">Kuroki et al. 2003</xref>) accords with the view that 5-HT<sub>2A</sub> receptor activation may also affect mesolimbic DA neurons.</p><p>In summary, the combined application of in situ hybridization and retrograde tract tracing enabled to show the presence of 5-HT<sub>2A</sub> receptor mRNA in pyramidal neurons of the medial and orbital divisions of the rat PFC that project to monoaminergic cell groups of the midbrain. This provides anatomical support for previous observations indicating a 5-HT<sub>2A</sub> receptor-mediated control of DA and 5-HT neurons and raises the possibility that atypical antipsychotic drugs may partly act by reducing excitatory PFC inputs onto subcortical structures, including the midbrain monoaminergic nuclei.</p></sec></sec><sec><title>Funding</title><p>SAF grants (2004-05525 and 2007-62378); SENY Fundaci&#x000f3;; FPU predoctoral fellowship from the Spanish Ministry of Education to P.V.B. Funding to pay the Open Access publication charges for this article were provided by SENY Fundaci&#x000f3;.</p></sec></body><back><ack><p>We thank Roc&#x000ed;o Mart&#x000ed;n for skillful technical assistance with in situ hybridization experiments. We also thank the personnel from &#x0201c;Serveis Cient&#x000ed;ficot&#x000e8;cnics&#x0201d; of the Universitat de Barcelona for their technical assistance in confocal microscopy. <italic>Conflict of Interest:</italic> None declared.</p></ack><ref-list><ref id="bib1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aghajanian</surname><given-names>GK</given-names></name><name><surname>Marek</surname><given-names>GJ</given-names></name></person-group><article-title>Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells</article-title><source>Neuropharmacology.</source><year>1997</year><volume>36</volume><fpage>589</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">9225284</pub-id></citation></ref><ref id="bib2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aghajanian</surname><given-names>GK</given-names></name><name><surname>Marek</surname><given-names>GJ</given-names></name></person-group><article-title>Serotonin, via 5-HT<sub>2A</sub> receptors, increases EPSCs in layer v pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release</article-title><source>Brain Res.</source><year>1999</year><volume>825</volume><fpage>161</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">10216183</pub-id></citation></ref><ref id="bib3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aghajanian</surname><given-names>GK</given-names></name><name><surname>Wang</surname><given-names>RY</given-names></name></person-group><article-title>Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique</article-title><source>Brain Res.</source><year>1977</year><volume>122</volume><fpage>229</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">837230</pub-id></citation></ref><ref id="bib4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amarg&#x000f3;s-Bosch</surname><given-names>M</given-names></name><name><surname>Bortolozzi</surname><given-names>A</given-names></name><name><surname>Puig</surname><given-names>MV</given-names></name><name><surname>Serrats</surname><given-names>J</given-names></name><name><surname>Adell</surname><given-names>A</given-names></name><name><surname>Celada</surname><given-names>P</given-names></name><name><surname>Toth</surname><given-names>M</given-names></name><name><surname>Mengod</surname><given-names>G</given-names></name><name><surname>Artigas</surname><given-names>F</given-names></name></person-group><article-title>Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex</article-title><source>Cereb Cortex.</source><year>2004</year><volume>14</volume><fpage>281</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">14754868</pub-id></citation></ref><ref id="bib5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andreasen</surname><given-names>NC</given-names></name><name><surname>O'Leary</surname><given-names>DS</given-names></name><name><surname>Flaum</surname><given-names>M</given-names></name><name><surname>Nopoulos</surname><given-names>P</given-names></name><name><surname>Watkins</surname><given-names>GL</given-names></name><name><surname>Boles Ponto</surname><given-names>LL</given-names></name><name><surname>Hichwa</surname><given-names>RD</given-names></name></person-group><article-title>Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients</article-title><source>Lancet.</source><year>1997</year><volume>349</volume><fpage>1730</fpage><lpage>1734</lpage><pub-id pub-id-type="pmid">9193383</pub-id></citation></ref><ref id="bib6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Araneda</surname><given-names>R</given-names></name><name><surname>Andrade</surname><given-names>R</given-names></name></person-group><article-title>5-Hydroxytryptamine<sub>2</sub> and 5-hydroxytryptamine<sub>1A</sub> receptors mediate opposing responses on membrane excitability in rat association cortex</article-title><source>Neuroscience.</source><year>1991</year><volume>40</volume><fpage>399</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">1851255</pub-id></citation></ref><ref id="bib7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnt</surname><given-names>J</given-names></name><name><surname>Skarsfeldt</surname><given-names>T</given-names></name></person-group><article-title>Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence</article-title><source>Neuropsychopharmacology.</source><year>1998</year><volume>18</volume><fpage>63</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">9430133</pub-id></citation></ref><ref id="bib8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barroso-Chinea</surname><given-names>P</given-names></name><name><surname>Castle</surname><given-names>M</given-names></name><name><surname>Aymerich</surname><given-names>MS</given-names></name><name><surname>Lanciego</surname><given-names>JL</given-names></name></person-group><article-title>Expression of vesicular glutamate transporters 1 and 2 in the cells of origin of the rat thalamostriatal pathway</article-title><source>J Chem Neuroanat.</source><year>2008</year><volume>35</volume><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">17826944</pub-id></citation></ref><ref id="bib9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benes</surname><given-names>FM</given-names></name><name><surname>Berretta</surname><given-names>S</given-names></name></person-group><article-title>GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder</article-title><source>Neuropsychopharmacology.</source><year>2001</year><volume>25</volume><fpage>1</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">11377916</pub-id></citation></ref><ref id="bib10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bortolozzi</surname><given-names>A</given-names></name><name><surname>D&#x000ed;az-Mataix</surname><given-names>L</given-names></name><name><surname>Scorza</surname><given-names>MC</given-names></name><name><surname>Celada</surname><given-names>P</given-names></name><name><surname>Artigas</surname><given-names>F</given-names></name></person-group><article-title>Activation of 5-HT<sub>2A</sub> receptors in prefrontal cortex enhances dopaminergic activity</article-title><source>J Neurochem.</source><year>2005</year><volume>95</volume><fpage>1597</fpage><lpage>1607</lpage><pub-id pub-id-type="pmid">16277612</pub-id></citation></ref><ref id="bib11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bymaster</surname><given-names>FP</given-names></name><name><surname>Hemrick-Luecke</surname><given-names>SK</given-names></name><name><surname>Perry</surname><given-names>KW</given-names></name><name><surname>Fuller</surname><given-names>RW</given-names></name></person-group><article-title>Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats</article-title><source>Psychopharmacology.</source><year>1996</year><volume>124</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">8935803</pub-id></citation></ref><ref id="bib12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>A</given-names></name></person-group><article-title>The current status of the dopamine hypothesis of schizophrenia</article-title><source>Neuropsychopharmacology.</source><year>1988</year><volume>1</volume><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">3075131</pub-id></citation></ref><ref id="bib13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>DB</given-names></name><name><surname>Sesack</surname><given-names>SR</given-names></name></person-group><article-title>Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons</article-title><source>J Neurosci.</source><year>2000</year><volume>20</volume><fpage>3864</fpage><lpage>3873</lpage><pub-id pub-id-type="pmid">10804226</pub-id></citation></ref><ref id="bib14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Catafau</surname><given-names>AM</given-names></name><name><surname>Parellada</surname><given-names>E</given-names></name><name><surname>Lomena</surname><given-names>FJ</given-names></name><name><surname>Bernardo</surname><given-names>M</given-names></name><name><surname>Pavia</surname><given-names>J</given-names></name><name><surname>Ros</surname><given-names>D</given-names></name><name><surname>Setoain</surname><given-names>J</given-names></name><name><surname>Gonzalez-Moncl&#x000fa;s</surname><given-names>E</given-names></name></person-group><article-title>Prefrontal and Temporal blood-flow in schizophrenia&#x02014;resting and activation technetium-99M-Hmpao spect patterns in young neuroleptic-naive patients with acute disease</article-title><source>J Nucl Med.</source><year>1994</year><volume>35</volume><fpage>935</fpage><lpage>941</lpage><pub-id pub-id-type="pmid">8195878</pub-id></citation></ref><ref id="bib15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Celada</surname><given-names>P</given-names></name><name><surname>Puig</surname><given-names>MV</given-names></name><name><surname>Casanovas</surname><given-names>JM</given-names></name><name><surname>Guillazo</surname><given-names>G</given-names></name><name><surname>Artigas</surname><given-names>F</given-names></name></person-group><article-title>Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors</article-title><source>J Neurosci.</source><year>2001</year><volume>21</volume><fpage>9917</fpage><lpage>9929</lpage><pub-id pub-id-type="pmid">11739599</pub-id></citation></ref><ref id="bib16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Celada</surname><given-names>P</given-names></name><name><surname>Puig</surname><given-names>MV</given-names></name><name><surname>D&#x000ed;az-Mataix</surname><given-names>L</given-names></name><name><surname>Artigas</surname><given-names>F</given-names></name></person-group><article-title>The hallucinogen DOI reduces low frequency oscillations in rat prefrontal cortex. Reversal by antipsychotic drugs</article-title><source>Biol Psychiatry.</source><year>2008</year><volume>64</volume><fpage>392</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">18436196</pub-id></citation></ref><ref id="bib17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Aston-Jones</surname><given-names>G</given-names></name></person-group><article-title>Evidence that cholera-toxin-B subunit (Ctb) can be avidly taken up and transported by fibers of passage</article-title><source>Brain Res.</source><year>1995</year><volume>674</volume><fpage>107</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">7773677</pub-id></citation></ref><ref id="bib18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>YH</given-names></name><name><surname>Halldin</surname><given-names>C</given-names></name><name><surname>Farde</surname><given-names>L</given-names></name></person-group><article-title>Occupancy of 5-HT<sub>1A</sub> receptors by clozapine in the primate brain: a PET study</article-title><source>Psychopharmacology (Berl).</source><year>2003</year><volume>166</volume><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">12589516</pub-id></citation></ref><ref id="bib19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dierks</surname><given-names>T</given-names></name><name><surname>Linden</surname><given-names>DE</given-names></name><name><surname>Jandl</surname><given-names>M</given-names></name><name><surname>Formisano</surname><given-names>E</given-names></name><name><surname>Goebel</surname><given-names>R</given-names></name><name><surname>Lanfermann</surname><given-names>H</given-names></name><name><surname>Singer</surname><given-names>W</given-names></name></person-group><article-title>Activation of Heschl's gyrus during auditory hallucinations</article-title><source>Neuron.</source><year>1999</year><volume>22</volume><fpage>615</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">10197540</pub-id></citation></ref><ref id="bib20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elvevag</surname><given-names>B</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name></person-group><article-title>Cognitive impairment in schizophrenia is the core of the disorder</article-title><source>Crit Rev Neurobiol.</source><year>2000</year><volume>14</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">11253953</pub-id></citation></ref><ref id="bib21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Floresco</surname><given-names>SB</given-names></name><name><surname>West</surname><given-names>AR</given-names></name><name><surname>Ash</surname><given-names>B</given-names></name><name><surname>Moore</surname><given-names>H</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name></person-group><article-title>Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission</article-title><source>Nat Neurosci.</source><year>2003</year><volume>6</volume><fpage>968</fpage><lpage>973</lpage><pub-id pub-id-type="pmid">12897785</pub-id></citation></ref><ref id="bib22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gabbott</surname><given-names>PLA</given-names></name><name><surname>Warner</surname><given-names>TA</given-names></name><name><surname>Jays</surname><given-names>PRL</given-names></name><name><surname>Salway</surname><given-names>P</given-names></name><name><surname>Busby</surname><given-names>SJ</given-names></name></person-group><article-title>Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers</article-title><source>J Comp Neurol.</source><year>2005</year><volume>492</volume><fpage>145</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">16196030</pub-id></citation></ref><ref id="bib23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geisler</surname><given-names>S</given-names></name><name><surname>Zahm</surname><given-names>DS</given-names></name></person-group><article-title>Afferents of the ventral tegmental area in the rat-anatomical substratum for integrative functions</article-title><source>J Comp Neurol.</source><year>2005</year><volume>490</volume><fpage>270</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">16082674</pub-id></citation></ref><ref id="bib24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gobert</surname><given-names>A</given-names></name><name><surname>Millan</surname><given-names>MJ</given-names></name></person-group><article-title>Serotonin (5-HT)(2A) receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats</article-title><source>Neuropharmacology.</source><year>1999</year><volume>38</volume><fpage>315</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">10218874</pub-id></citation></ref><ref id="bib25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Maeso</surname><given-names>J</given-names></name><name><surname>Weisstaub</surname><given-names>NV</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>P</given-names></name><name><surname>Ivic</surname><given-names>L</given-names></name><name><surname>Ang</surname><given-names>R</given-names></name><name><surname>Lira</surname><given-names>A</given-names></name><name><surname>Bradley-Moore</surname><given-names>M</given-names></name><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior</article-title><source>Neuron.</source><year>2007</year><volume>53</volume><fpage>439</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">17270739</pub-id></citation></ref><ref id="bib26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haj&#x000f3;s</surname><given-names>M</given-names></name><name><surname>Richards</surname><given-names>CD</given-names></name><name><surname>Szekely</surname><given-names>AD</given-names></name><name><surname>Sharp</surname><given-names>T</given-names></name></person-group><article-title>An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat</article-title><source>Neuroscience.</source><year>1998</year><volume>87</volume><fpage>95</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">9722144</pub-id></citation></ref><ref id="bib27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>PJ</given-names></name></person-group><article-title>The neuropathology of schizophrenia&#x02014;a critical review of the data and their interpretation</article-title><source>Brain.</source><year>1999</year><volume>122</volume><fpage>593</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">10219775</pub-id></citation></ref><ref id="bib28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>EE</given-names></name><name><surname>Zaborszky</surname><given-names>L</given-names></name></person-group><article-title>Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization study [corrected]</article-title><source>J Comp Neurol.</source><year>2005</year><volume>483</volume><fpage>351</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">15682395</pub-id></citation></ref><ref id="bib29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ichikawa</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Meltzer</surname><given-names>HY</given-names></name></person-group><article-title>DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release</article-title><source>Brain Res.</source><year>2001</year><volume>907</volume><fpage>151</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">11430898</pub-id></citation></ref><ref id="bib30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>BL</given-names></name><name><surname>Azmitia</surname><given-names>EC</given-names></name></person-group><article-title>Structure and function of the brain serotonin system</article-title><source>Physiol Rev.</source><year>1992</year><volume>72</volume><fpage>165</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">1731370</pub-id></citation></ref><ref id="bib31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jankowski</surname><given-names>MP</given-names></name><name><surname>Sesack</surname><given-names>SR</given-names></name></person-group><article-title>Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons</article-title><source>J Comp Neurol.</source><year>2004</year><volume>468</volume><fpage>518</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">14689484</pub-id></citation></ref><ref id="bib32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kapur</surname><given-names>S</given-names></name><name><surname>Zipursky</surname><given-names>RB</given-names></name><name><surname>Remington</surname><given-names>G</given-names></name></person-group><article-title>Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia</article-title><source>Am J Psychiatry.</source><year>1999</year><volume>156</volume><fpage>286</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">9989565</pub-id></citation></ref><ref id="bib33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuroki</surname><given-names>T</given-names></name><name><surname>Meltzer</surname><given-names>HY</given-names></name><name><surname>Ichikawa</surname><given-names>J</given-names></name></person-group><article-title>5-HT<sub>2A</sub> receptor stimulation by DOI, a 5-HT<sub>2A/2C</sub> receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens</article-title><source>Brain Res.</source><year>2003</year><volume>972</volume><fpage>216</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">12711095</pub-id></citation></ref><ref id="bib34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lambe</surname><given-names>EK</given-names></name><name><surname>Aghajanian</surname><given-names>GK</given-names></name></person-group><article-title>Prefrontal cortical network activity: opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activation</article-title><source>Neuroscience.</source><year>2007</year><volume>145</volume><fpage>900</fpage><lpage>910</lpage><pub-id pub-id-type="pmid">17293055</pub-id></citation></ref><ref id="bib35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lammel</surname><given-names>S</given-names></name><name><surname>Hetzel</surname><given-names>A</given-names></name><name><surname>Hackel</surname><given-names>O</given-names></name><name><surname>Jones</surname><given-names>I</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name><name><surname>Roeper</surname><given-names>J</given-names></name></person-group><article-title>Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system</article-title><source>Neuron.</source><year>2008</year><volume>57</volume><fpage>760</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">18341995</pub-id></citation></ref><ref id="bib36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laruelle</surname><given-names>M</given-names></name><name><surname>Abi-Dargham</surname><given-names>A</given-names></name><name><surname>van Dyck</surname><given-names>CH</given-names></name><name><surname>Gil</surname><given-names>R</given-names></name><name><surname>D'Souza</surname><given-names>CD</given-names></name><name><surname>Erdos</surname><given-names>J</given-names></name><name><surname>McCance</surname><given-names>E</given-names></name><name><surname>Rosenblatt</surname><given-names>W</given-names></name><name><surname>Fingado</surname><given-names>C</given-names></name><name><surname>Zoghbi</surname><given-names>SS</given-names></name><name><surname>Baldwin</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects</article-title><source>Proc Natl Acad Sci USA.</source><year>1996</year><volume>93</volume><fpage>9235</fpage><lpage>9240</lpage><pub-id pub-id-type="pmid">8799184</pub-id></citation></ref><ref id="bib37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Volk</surname><given-names>DW</given-names></name></person-group><article-title>Cortical inhibitory neurons and schizophrenia</article-title><source>Nat Rev Neurosci.</source><year>2005</year><volume>6</volume><fpage>312</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">15803162</pub-id></citation></ref><ref id="bib38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Lieberman</surname><given-names>JA</given-names></name></person-group><article-title>Catching up on schizophrenia: natural history and neurobiology</article-title><source>Neuron.</source><year>2000</year><volume>28</volume><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">11144342</pub-id></citation></ref><ref id="bib39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n-Ruiz</surname><given-names>R</given-names></name><name><surname>Puig</surname><given-names>MV</given-names></name><name><surname>Celada</surname><given-names>P</given-names></name><name><surname>Shapiro</surname><given-names>DA</given-names></name><name><surname>Roth</surname><given-names>BL</given-names></name><name><surname>Mengod</surname><given-names>G</given-names></name><name><surname>Artigas</surname><given-names>F</given-names></name></person-group><article-title>Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism</article-title><source>J Neurosci.</source><year>2001</year><volume>21</volume><fpage>9856</fpage><lpage>9866</lpage><pub-id pub-id-type="pmid">11739593</pub-id></citation></ref><ref id="bib40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meltzer</surname><given-names>HY</given-names></name></person-group><article-title>The role of serotonin in antipsychotic drug action</article-title><source>Neuropsychopharmacology.</source><year>1999</year><volume>21</volume><fpage>S106</fpage><lpage>S115</lpage></citation></ref><ref id="bib41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minabe</surname><given-names>Y</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>KI</given-names></name><name><surname>Ashby</surname><given-names>CR</given-names><suffix>Jr</suffix></name></person-group><article-title>Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study</article-title><source>Synapse.</source><year>2001</year><volume>40</volume><fpage>102</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">11252021</pub-id></citation></ref><ref id="bib42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nocjar</surname><given-names>C</given-names></name><name><surname>Roth</surname><given-names>BL</given-names></name><name><surname>Pehek</surname><given-names>EA</given-names></name></person-group><article-title>Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group</article-title><source>Neuroscience.</source><year>2002</year><volume>111</volume><fpage>163</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">11955720</pub-id></citation></ref><ref id="bib43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordstrom</surname><given-names>AL</given-names></name><name><surname>Nyberg</surname><given-names>S</given-names></name><name><surname>Olsson</surname><given-names>H</given-names></name><name><surname>Farde</surname><given-names>L</given-names></name></person-group><article-title>Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients</article-title><source>Arch Gen Psychiatry.</source><year>1998</year><volume>55</volume><fpage>283</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">9510228</pub-id></citation></ref><ref id="bib44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nyberg</surname><given-names>S</given-names></name><name><surname>Eriksson</surname><given-names>B</given-names></name><name><surname>Oxenstierna</surname><given-names>G</given-names></name><name><surname>Halldin</surname><given-names>C</given-names></name><name><surname>Farde</surname><given-names>L</given-names></name></person-group><article-title>Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT<sub>2A</sub> receptor occupancy in schizophrenic patients</article-title><source>Am J Psychiatry.</source><year>1999</year><volume>156</volume><fpage>869</fpage><lpage>875</lpage><pub-id pub-id-type="pmid">10360125</pub-id></citation></ref><ref id="bib45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nyberg</surname><given-names>S</given-names></name><name><surname>Nilsson</surname><given-names>U</given-names></name><name><surname>Okubo</surname><given-names>Y</given-names></name><name><surname>Halldin</surname><given-names>C</given-names></name><name><surname>Farde</surname><given-names>L</given-names></name></person-group><article-title>Implications of brain imaging for the management of schizophrenia</article-title><source>Int Clin Psychopharmacol.</source><year>1998</year><volume>13</volume><issue>Suppl. 3</issue><fpage>S15</fpage><lpage>S20</lpage><pub-id pub-id-type="pmid">9690965</pub-id></citation></ref><ref id="bib46"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G</given-names></name><name><surname>Watson</surname><given-names>C</given-names></name></person-group><source>The rat brain in stereotaxic coordinates</source><year>1986</year><publisher-loc>Sydney</publisher-loc><publisher-name>Academic Press</publisher-name></citation></ref><ref id="bib47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pazos</surname><given-names>A</given-names></name><name><surname>Cort&#x000e9;s</surname><given-names>R</given-names></name><name><surname>Palacios</surname><given-names>JM</given-names></name></person-group><article-title>Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors</article-title><source>Brain Res.</source><year>1985</year><volume>346</volume><fpage>231</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">4052777</pub-id></citation></ref><ref id="bib48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pehek</surname><given-names>EA</given-names></name><name><surname>McFarlane</surname><given-names>HG</given-names></name><name><surname>Maguschak</surname><given-names>K</given-names></name><name><surname>Price</surname><given-names>B</given-names></name><name><surname>Pluto</surname><given-names>CP</given-names></name></person-group><article-title>M100,907, a selective 5-HT<sub>2A</sub> antagonist, attenuates dopamine release in the rat medial prefrontal cortex</article-title><source>Brain Res.</source><year>2001</year><volume>888</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">11146051</pub-id></citation></ref><ref id="bib49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez-Manso</surname><given-names>M</given-names></name><name><surname>Barroso-Chinea</surname><given-names>P</given-names></name><name><surname>Aymerich</surname><given-names>MS</given-names></name><name><surname>Lanciego</surname><given-names>JL</given-names></name></person-group><article-title>&#x02018;Functional&#x02019; neuroanatomical tract tracing: analysis of changes in gene expression of brain circuits of interest</article-title><source>Brain Res.</source><year>2006</year><volume>1072</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">16423326</pub-id></citation></ref><ref id="bib50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peyron</surname><given-names>C</given-names></name><name><surname>Petit</surname><given-names>JM</given-names></name><name><surname>Rampon</surname><given-names>C</given-names></name><name><surname>Jouvet</surname><given-names>M</given-names></name><name><surname>Luppi</surname><given-names>PH</given-names></name></person-group><article-title>Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods</article-title><source>Neuroscience.</source><year>1998</year><volume>82</volume><fpage>443</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">9466453</pub-id></citation></ref><ref id="bib51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pompeiano</surname><given-names>M</given-names></name><name><surname>Palacios</surname><given-names>JM</given-names></name><name><surname>Mengod</surname><given-names>G</given-names></name></person-group><article-title>Distribution and cellular localization of mRNA coding for 5-HT<sub>1A</sub> receptor in the rat brain: correlation with receptor binding</article-title><source>J Neurosci.</source><year>1992</year><volume>12</volume><fpage>440</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">1531498</pub-id></citation></ref><ref id="bib52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pompeiano</surname><given-names>M</given-names></name><name><surname>Palacios</surname><given-names>JM</given-names></name><name><surname>Mengod</surname><given-names>G</given-names></name></person-group><article-title>Distribution of the serotonin 5-HT<sub>2</sub> receptor family mRNAs: comparison between 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors</article-title><source>Mol Brain Res.</source><year>1994</year><volume>23</volume><fpage>163</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">8028479</pub-id></citation></ref><ref id="bib53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porras</surname><given-names>G</given-names></name><name><surname>Di</surname><given-names>MV</given-names></name><name><surname>Fracasso</surname><given-names>C</given-names></name><name><surname>Lucas</surname><given-names>G</given-names></name><name><surname>De Deurwaerdere</surname><given-names>P</given-names></name><name><surname>Caccia</surname><given-names>S</given-names></name><name><surname>Esposito</surname><given-names>E</given-names></name><name><surname>Spampinato</surname><given-names>U</given-names></name></person-group><article-title>5-HT<sub>2A</sub> and 5-HT<sub>2C/2B</sub> receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum</article-title><source>Neuropsychopharmacology.</source><year>2002</year><volume>26</volume><fpage>311</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">11850146</pub-id></citation></ref><ref id="bib54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potkin</surname><given-names>SG</given-names></name><name><surname>Alva</surname><given-names>G</given-names></name><name><surname>Fleming</surname><given-names>K</given-names></name><name><surname>Anand</surname><given-names>R</given-names></name><name><surname>Keator</surname><given-names>D</given-names></name><name><surname>Carreon</surname><given-names>D</given-names></name><name><surname>Doo</surname><given-names>M</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>JC</given-names></name><name><surname>Fallon</surname><given-names>JH</given-names></name></person-group><article-title>A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography</article-title><source>Am J Psychiatry.</source><year>2002</year><volume>159</volume><fpage>227</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">11823264</pub-id></citation></ref><ref id="bib55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pritchett</surname><given-names>DB</given-names></name><name><surname>Bach</surname><given-names>AW</given-names></name><name><surname>Wozny</surname><given-names>M</given-names></name><name><surname>Taleb</surname><given-names>O</given-names></name><name><surname>Dal Toso</surname><given-names>R</given-names></name><name><surname>Shih</surname><given-names>JC</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name></person-group><article-title>Structure and functional expression of cloned rat serotonin 5HT-2 receptor</article-title><source>EMBO J.</source><year>1988</year><volume>20</volume><fpage>4135</fpage><lpage>4140</lpage><pub-id pub-id-type="pmid">2854054</pub-id></citation></ref><ref id="bib56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puig</surname><given-names>MV</given-names></name><name><surname>Artigas</surname><given-names>F</given-names></name><name><surname>Celada</surname><given-names>P</given-names></name></person-group><article-title>Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA</article-title><source>Cereb Cortex.</source><year>2005</year><volume>15</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15238448</pub-id></citation></ref><ref id="bib57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puig</surname><given-names>MV</given-names></name><name><surname>Celada</surname><given-names>P</given-names></name><name><surname>Diaz-Mataix</surname><given-names>L</given-names></name><name><surname>Artigas</surname><given-names>F</given-names></name></person-group><article-title>In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT<sub>2A</sub> receptors: relationship to thalamocortical afferents</article-title><source>Cereb Cortex.</source><year>2003</year><volume>13</volume><fpage>870</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">12853374</pub-id></citation></ref><ref id="bib58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group><article-title>Chemical neuromodulation of frontal-executive functions in humans and other animals</article-title><source>Exp Brain Res.</source><year>2000</year><volume>133</volume><fpage>130</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">10933217</pub-id></citation></ref><ref id="bib59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santana</surname><given-names>N</given-names></name><name><surname>Bortolozzi</surname><given-names>A</given-names></name><name><surname>Serrats</surname><given-names>J</given-names></name><name><surname>Mengod</surname><given-names>G</given-names></name><name><surname>Artigas</surname><given-names>F</given-names></name></person-group><article-title>Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex</article-title><source>Cereb Cortex.</source><year>2004</year><volume>14</volume><fpage>1100</fpage><lpage>1109</lpage><pub-id pub-id-type="pmid">15115744</pub-id></citation></ref><ref id="bib60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname><given-names>W</given-names></name></person-group><article-title>Neural coding of basic reward terms of animal learning theory, game theory, microeconomics and behavioural ecology</article-title><source>Curr Opin Neurobiol.</source><year>2004</year><volume>14</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">15082317</pub-id></citation></ref><ref id="bib61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selemon</surname><given-names>LD</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group><article-title>The reduced neuropil hypothesis: a circuit based model of schizophrenia</article-title><source>Biol Psychiatry.</source><year>1999</year><volume>45</volume><fpage>17</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">9894571</pub-id></citation></ref><ref id="bib62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sesack</surname><given-names>SR</given-names></name><name><surname>Deutch</surname><given-names>AY</given-names></name><name><surname>Roth</surname><given-names>RH</given-names></name><name><surname>Bunney</surname><given-names>BS</given-names></name></person-group><article-title>Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin</article-title><source>J Comp Neurol.</source><year>1989</year><volume>290</volume><fpage>213</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">2592611</pub-id></citation></ref><ref id="bib63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shergill</surname><given-names>SS</given-names></name><name><surname>Brammer</surname><given-names>MJ</given-names></name><name><surname>Williams</surname><given-names>SC</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name><name><surname>McGuire</surname><given-names>PK</given-names></name></person-group><article-title>Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging</article-title><source>Arch Gen Psychiatry.</source><year>2000</year><volume>57</volume><fpage>1033</fpage><lpage>1038</lpage><pub-id pub-id-type="pmid">11074868</pub-id></citation></ref><ref id="bib64"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>LW</given-names></name></person-group><source>Structure of the rat brain</source><year>1999</year><publisher-loc>Amsterdam</publisher-loc><publisher-name>Elsevier</publisher-name></citation></ref><ref id="bib65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>E</given-names></name><name><surname>North</surname><given-names>RA</given-names></name></person-group><article-title>Actions of 5 hydroxytryptamine on neurons of the rat cingulate cortex</article-title><source>J Neurophysiol.</source><year>1993</year><volume>69</volume><fpage>1749</fpage><lpage>1757</lpage><pub-id pub-id-type="pmid">8389838</pub-id></citation></ref><ref id="bib66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thierry</surname><given-names>AM</given-names></name><name><surname>Deniau</surname><given-names>JM</given-names></name><name><surname>Chevalier</surname><given-names>G</given-names></name><name><surname>Ferron</surname><given-names>A</given-names></name><name><surname>Glowinski</surname><given-names>J</given-names></name></person-group><article-title>An electrophysiological analysis of some afferent and efferent pathways of the rat prefrontal cortex</article-title><source>Prog Brain Res.</source><year>1983</year><volume>58</volume><fpage>257</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">6415755</pub-id></citation></ref><ref id="bib67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thierry</surname><given-names>AM</given-names></name><name><surname>Deniau</surname><given-names>JM</given-names></name><name><surname>Feger</surname><given-names>J</given-names></name></person-group><article-title>Effects of stimulation of the frontal-cortex on identified output VMT cells in the rat</article-title><source>Neurosci Lett.</source><year>1979</year><volume>15</volume><fpage>103</fpage><lpage>107</lpage></citation></ref><ref id="bib68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomiyama</surname><given-names>M</given-names></name><name><surname>Palacios</surname><given-names>JM</given-names></name><name><surname>Cortes</surname><given-names>R</given-names></name><name><surname>Vilaro</surname><given-names>MT</given-names></name><name><surname>Mengod</surname><given-names>G</given-names></name></person-group><article-title>Distribution of AMPA receptor subunit mRNAs in the human basal ganglia: an in situ hybridization study</article-title><source>Mol Brain Res.</source><year>1997</year><volume>46</volume><fpage>281</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">9191103</pub-id></citation></ref><ref id="bib69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>ZY</given-names></name><name><surname>Overton</surname><given-names>PG</given-names></name><name><surname>Clark</surname><given-names>D</given-names></name></person-group><article-title>Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events</article-title><source>Synapse.</source><year>1996</year><volume>22</volume><fpage>195</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">9132987</pub-id></citation></ref><ref id="bib70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>ZY</given-names></name><name><surname>Overton</surname><given-names>PG</given-names></name><name><surname>Martinez-Cue</surname><given-names>C</given-names></name><name><surname>Clark</surname><given-names>D</given-names></name></person-group><article-title>Do non-dopaminergic neurons in the ventral tegmental area play a role in the responses elicited in A10 dopaminergic neurons by electrical stimulation of the prefrontal cortex?</article-title><source>Exp Brain Res.</source><year>1998</year><volume>118</volume><fpage>466</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">9504842</pub-id></citation></ref><ref id="bib71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tzschentke</surname><given-names>TM</given-names></name><name><surname>Schmidt</surname><given-names>WJ</given-names></name></person-group><article-title>Functional relationship among medial prefrontal cortex, nucleus accumbens, and ventral tegmental area in locomotion and reward</article-title><source>Crit Rev Neurobiol.</source><year>2000</year><volume>14</volume><fpage>131</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">11513242</pub-id></citation></ref><ref id="bib72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villalobos</surname><given-names>C</given-names></name><name><surname>B&#x000e9;ique</surname><given-names>JC</given-names></name><name><surname>Gingrich</surname><given-names>JA</given-names></name><name><surname>Andrade</surname><given-names>R</given-names></name></person-group><article-title>Serotonergic regulation of calcium-activated potassium currents in rodent prefrontal cortex</article-title><source>Eur J Neurosci.</source><year>2005</year><volume>22</volume><fpage>1120</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">16176353</pub-id></citation></ref><ref id="bib73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Aloia</surname><given-names>MS</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name><name><surname>Berman</surname><given-names>KF</given-names></name></person-group><article-title>The frontal lobes and schizophrenia</article-title><source>J Neuropsychiatry Clin Neurosci.</source><year>1994</year><volume>6</volume><fpage>419</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">7841813</pub-id></citation></ref><ref id="bib74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Lipska</surname><given-names>BK</given-names></name><name><surname>Berman</surname><given-names>KF</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name></person-group><article-title>Prefrontal neurons and the genetics of schizophrenia</article-title><source>Biol Psychiatry.</source><year>2001</year><volume>50</volume><fpage>825</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">11743939</pub-id></citation></ref><ref id="bib75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>GV</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group><article-title>Modulation of memory fields by dopamine D1 receptors in prefrontal cortex</article-title><source>Nature.</source><year>1995</year><volume>376</volume><fpage>572</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">7637804</pub-id></citation></ref><ref id="bib76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yokota</surname><given-names>S</given-names></name><name><surname>Oka</surname><given-names>T</given-names></name><name><surname>Tsumori</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Yasui</surname><given-names>Y</given-names></name></person-group><article-title>Glutamatergic neurons in the Kolliker-Fuse nucleus project to the rostral ventral respiratory group and phrenic nucleus: a combined retrograde tracing and in situ hybridization study in the rat</article-title><source>Neurosci Res.</source><year>2007</year><volume>59</volume><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">17888537</pub-id></citation></ref><ref id="bib77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>FM</given-names></name><name><surname>Hablitz</surname><given-names>JJ</given-names></name></person-group><article-title>Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex</article-title><source>J Neurophysiol.</source><year>1999</year><volume>82</volume><fpage>2989</fpage><lpage>2999</lpage><pub-id pub-id-type="pmid">10601434</pub-id></citation></ref></ref-list></back></article> 